An apparatus for sanitizing is provided. The apparatus includes a housing having a reservoir for retaining sanitizing fluid. The apparatus also includes a holder disposed beneath the housing. The apparatus further includes an applicator pad received by the holder and adapted to be in selective fluid communication with the reservoir. The applicator pad includes a dome-shaped portion having a substantially hemi-spherical shape configured to extend into an interior region of a bell of a stethoscope head when the bell is placed over the dome-shaped portion.

An apparatus for sanitizing is provided. The apparatus includes a housing having a reservoir for retaining sanitizing fluid. The apparatus also includes a holder disposed beneath the housing. The apparatus further includes an applicator pad received by the holder and adapted to be in selective fluid communication with the reservoir. The applicator pad includes a dome-shaped portion having a substantially hemi-spherical shape configured to extend into an interior region of a bell of a stethoscope head when the bell is placed over the dome-shaped portion.

A formulation for providing a disinfecting foam on the basis of an electrochemically activated aqueous saline solution enabling the dispensation as a foam while the microbicidal effectivity the electrochemically activated saline solution is maintained is to be provided. To this end, the formulation comprises at least one surfactant foam carrier component and at least one antimicrobially effective component on the basis of a electrochemically activated aqueous saline solution, the formulation having a content of at least 10 ppm of a free chlorine species selected from the group comprising hydrochlorous acid, hypochlorite ions, sodium hypochlorite or dissolved chlorine gas, and exhibiting a vibration band associated with a CF vibration in the infrared spectrum.

A formulation for providing a disinfecting foam on the basis of an electrochemically activated aqueous saline solution enabling the dispensation as a foam while the microbicidal effectivity the electrochemically activated saline solution is maintained is to be provided. To this end, the formulation comprises at least one surfactant foam carrier component and at least one antimicrobially effective component on the basis of a electrochemically activated aqueous saline solution, the formulation having a content of at least 10 ppm of a free chlorine species selected from the group comprising hydrochlorous acid, hypochlorite ions, sodium hypochlorite or dissolved chlorine gas, and exhibiting a vibration band associated with a CF vibration in the infrared spectrum.

A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.

A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.

An apparatus for sanitizing is provided. The apparatus includes a housing having a reservoir for retaining sanitizing fluid. The apparatus also includes a holder disposed beneath the housing. The apparatus further includes an applicator pad received by the holder and adapted to be in selective fluid communication with the reservoir. The applicator pad includes a dome-shaped portion having a substantially hemi-spherical shape configured to extend into an interior region of a bell of a stethoscope head when the bell is placed over the dome-shaped portion.

An apparatus for sanitizing is provided. The apparatus includes a housing having a reservoir for retaining sanitizing fluid. The apparatus also includes a holder disposed beneath the housing. The apparatus further includes an applicator pad received by the holder and adapted to be in selective fluid communication with the reservoir. The applicator pad includes a dome-shaped portion having a substantially hemi-spherical shape configured to extend into an interior region of a bell of a stethoscope head when the bell is placed over the dome-shaped portion.

The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.

The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.